Harpoon Therapeutics, Inc.

NASDAQ:HARP

23.01 (USD) • At close March 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2022202120202019201820172016
Revenue 31.91523.65417.4445.7774.750.7080
Cost of Revenue 3.0972.64600000
Gross Profit 28.81821.00817.4445.7774.750.7080
Gross Profit Ratio 0.9030.88811110
Reseach & Development Expenses 81.39372.12452.56541.59226.36813.6227.778
General & Administrative Expenses 18.84718.32716.2122.3916.1063.6143.369
Selling & Marketing Expenses 0000000
SG&A 18.84718.32716.2122.3916.1063.6143.369
Other Expenses -0.182-0.21-0.026-0.042-0.037-0.017-0.004
Operating Expenses 100.2490.45168.77563.98332.47417.23611.147
Operating Income -68.325-116.751-51.331-58.206-27.724-16.528-11.147
Operating Income Ratio -2.141-4.936-2.943-10.075-5.837-23.3450
Total Other Income Expenses Net 0.5940.031.4232.634-0.037-0.017-0.004
Income Before Tax -67.731-116.721-49.908-55.572-27.366-16.83-11.406
Income Before Tax Ratio -2.122-4.935-2.861-9.62-5.761-23.7710
Income Tax Expense -0.59449.714-3.531-3.5760.3580.2680.257
Net Income -67.137-166.435-46.377-51.996-27.366-16.83-11.406
Net Income Ratio -2.104-7.036-2.659-9.001-5.761-23.7710
EPS -20.24-51.57-18.52-23.91-11.45-17.81-1.21
EPS Diluted -20.24-51.57-18.52-23.91-11.45-17.81-1.21
EBITDA -68.325-14.653-51.331-58.206-27.366-16.179-10.947
EBITDA Ratio -2.141-0.619-2.943-10.075-5.761-22.8520